These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 15082580

  • 1. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies.
    Korponay-Szabó IR, Halttunen T, Szalai Z, Laurila K, Király R, Kovács JB, Fésüs L, Mäki M.
    Gut; 2004 May; 53(5):641-8. PubMed ID: 15082580
    [Abstract] [Full Text] [Related]

  • 2. Missing endomysial and reticulin binding of coeliac antibodies in transglutaminase 2 knockout tissues.
    Korponay-Szabó IR, Laurila K, Szondy Z, Halttunen T, Szalai Z, Dahlbom I, Rantala I, Kovács JB, Fésüs L, Mäki M.
    Gut; 2003 Feb; 52(2):199-204. PubMed ID: 12524400
    [Abstract] [Full Text] [Related]

  • 3. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits.
    Salmi TT, Collin P, Korponay-Szabó IR, Laurila K, Partanen J, Huhtala H, Király R, Lorand L, Reunala T, Mäki M, Kaukinen K.
    Gut; 2006 Dec; 55(12):1746-53. PubMed ID: 16571636
    [Abstract] [Full Text] [Related]

  • 4. High density of intraepithelial gammadelta lymphocytes and deposits of immunoglobulin (Ig)M anti-tissue transglutaminase antibodies in the jejunum of coeliac patients with IgA deficiency.
    Borrelli M, Maglio M, Agnese M, Paparo F, Gentile S, Colicchio B, Tosco A, Auricchio R, Troncone R.
    Clin Exp Immunol; 2010 May; 160(2):199-206. PubMed ID: 20030673
    [Abstract] [Full Text] [Related]

  • 5. Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay.
    Mankaï A, Sakly W, Landolsi H, Gueddah L, Sriha B, Ayadi A, Sfar MT, Skandrani K, Harbi A, Essoussi AS, Korbi S, Fabien N, Jeddi M, Ghedira I.
    Pathol Biol (Paris); 2005 May; 53(4):204-9. PubMed ID: 15850953
    [Abstract] [Full Text] [Related]

  • 6. Intestinal anti-transglutaminase 2 immunoglobulin A deposits in children at risk for coeliac disease (CD): data from the PreventCD study.
    Borrelli M, Maglio M, Korponay-Szabó IR, Vass V, Mearin ML, Meijer C, Niv-Drori H, Ribes-Koninckx C, Roca M, Shamir R, Troncone R, Auricchio R.
    Clin Exp Immunol; 2018 Mar; 191(3):311-317. PubMed ID: 29114847
    [Abstract] [Full Text] [Related]

  • 7. Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency.
    Korponay-Szabó IR, Dahlbom I, Laurila K, Koskinen S, Woolley N, Partanen J, Kovács JB, Mäki M, Hansson T.
    Gut; 2003 Nov; 52(11):1567-71. PubMed ID: 14570724
    [Abstract] [Full Text] [Related]

  • 8. Comparison of tissue transglutaminase-specific antibody assays with established antibody measurements for coeliac disease.
    Bazzigaluppi E, Lampasona V, Barera G, Venerando A, Bianchi C, Chiumello G, Bonifacio E, Bosi E.
    J Autoimmun; 1999 Feb; 12(1):51-6. PubMed ID: 10028022
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase.
    Dahlbom I, Korponay-Szabó IR, Kovács JB, Szalai Z, Mäki M, Hansson T.
    J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):140-6. PubMed ID: 19841593
    [Abstract] [Full Text] [Related]

  • 11. Role of human-tissue transglutaminase IgG and anti-gliadin IgG antibodies in the diagnosis of coeliac disease in patients with selective immunoglobulin A deficiency.
    Lenhardt A, Plebani A, Marchetti F, Gerarduzzi T, Not T, Meini A, Villanacci V, Martelossi S, Ventura A.
    Dig Liver Dis; 2004 Nov; 36(11):730-4. PubMed ID: 15571003
    [Abstract] [Full Text] [Related]

  • 12. Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease.
    Koskinen O, Villanen M, Korponay-Szabo I, Lindfors K, Mäki M, Kaukinen K.
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):559-65. PubMed ID: 19412007
    [Abstract] [Full Text] [Related]

  • 13. Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb angiogenesis.
    Myrsky E, Kaukinen K, Syrjänen M, Korponay-Szabó IR, Mäki M, Lindfors K.
    Clin Exp Immunol; 2008 Apr; 152(1):111-9. PubMed ID: 18279443
    [Abstract] [Full Text] [Related]

  • 14. Small-intestinal TG2-specific plasma cells at different stages of coeliac disease.
    Hietikko M, Koskinen O, Kurppa K, Laurila K, Saavalainen P, Salmi T, Ilus T, Huhtala H, Kaukinen K, Lindfors K.
    BMC Immunol; 2018 Dec 06; 19(1):36. PubMed ID: 30522434
    [Abstract] [Full Text] [Related]

  • 15. Intestinal anti-tissue transglutaminase antibodies in potential coeliac disease.
    Tosco A, Aitoro R, Auricchio R, Ponticelli D, Miele E, Paparo F, Greco L, Troncone R, Maglio M.
    Clin Exp Immunol; 2013 Jan 06; 171(1):69-75. PubMed ID: 23199325
    [Abstract] [Full Text] [Related]

  • 16. Transglutaminase and coeliac disease: endomysial reactivity and small bowel expression.
    Brusco G, Muzi P, Ciccocioppo R, Biagi F, Cifone MG, Corazza GR.
    Clin Exp Immunol; 1999 Dec 06; 118(3):371-5. PubMed ID: 10594554
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Detection of anti-endomysial and anti-tissue transglutaminase autoantibodies in media following culture of oral biopsies from patients with untreated coeliac disease.
    Vetrano S, Zampaletta U, Anania MC, Di Tola M, Sabbatella L, Passarelli F, Maffia C, Sanjust MG, Lettieri F, De Pità O, Picarelli A.
    Dig Liver Dis; 2007 Oct 06; 39(10):911-6. PubMed ID: 17719860
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.